June 26, 2025 a 12:38 pm
CNC: Analysts Ratings - Centene Corporation
Centene Corporation, operating in the complex healthcare sector, has maintained a dynamic analyst sentiment over recent months. While there is a forecast of stability given its important role in under-insured markets, investors should watch trends in analyst ratings for shifts. This company's market position amidst healthcare policy changes makes its stock a noteworthy consideration.
Historical Stock Grades
An analysis of the latest analyst ratings for Centene Corporation as of June 2025 indicates a bullish sentiment with 3 Strong Buy, 7 Buy, and 10 Hold ratings. The complete absence of Sell and Strong Sell recommendations suggests stability and positive market perception.
| Rating | Count | Score |
|---|---|---|
| Strong Buy | 3 | |
| Buy | 7 | |
| Hold | 10 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
Over the past year, there is a noticeable shift in the analyst ratings for Centene Corporation, indicative of cautious optimism.
- The number of analysts suggesting Strong Buy has slightly decreased.
- Hold ratings have increased, suggesting a more conservative stance.
- Aggregate analyst sentiment has been stable yet cautious, reflecting potential headwinds in the healthcare sector.
Percentage Trends
Observations over the past months indicate subtle shifts in analyst sentiment, which merit attention for future investment decisions.
- Strong Buy ratings have decreased from 6 to 3 over the past year.
- Hold ratings have increased, indicating less aggressive stances.
- The overall distribution points to a reduced emphasis on Strong Buy, with Buy and Hold stable, commenting on the broad sentiment.
Latest Analyst Recommendations
Recent analyst activity shows varied opinions about Centene Corporation's stock prospects. A detailed table of the latest recommendations provides more insights.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-06-02 | Equal Weight | Overweight | Barclays |
| 2025-04-29 | Hold | Hold | Jefferies |
| 2025-04-29 | Neutral | Neutral | Guggenheim |
| 2025-04-28 | Overweight | Overweight | Barclays |
| 2025-04-15 | Neutral | Neutral | Baird |
Analyst Recommendations with Change of Opinion
The recent changes in analyst recommendations highlight a more conservative approach. Several adjustments reflect evolving market conditions and outlook adjustments.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-06-02 | Equal Weight | Overweight | Barclays |
| 2025-04-08 | Hold | Underperform | Jefferies |
| 2024-12-13 | Buy | Neutral | UBS |
| 2024-12-10 | Underperform | Hold | Jefferies |
| 2024-07-24 | Hold | Buy | Jefferies |
Interpretation
The consistent shift towards Hold recommendations indicates a cautious market expectation for Centene Corporation. The stability in Hold and the declining Strong Buy ratings suggest some uncertainty or a wait-and-see approach. Despite this, the absence of negative ratings (Sell/Strong Sell) reflects a continued belief in the company's underlying stability and market position. The analyst sentiment appears carefully monitored, indicating readiness to respond to future market or sector-specific shifts.
Conclusion
Centene Corporation’s analyst ratings reflect a cautious yet stable outlook. Analysts display a trend towards maintaining positions rather than aggressive buying, suggesting the market sees Centene as steady but with some caution. This reflects on current healthcare sector uncertainties and potential policy impacts. For potential investors, understanding these dynamics is crucial; the stock is seen as a stable option amidst market fluctuations, carrying both opportunities for steady growth and potential risks tied to broader health sector changes.